Geneesmiddelenbewaking II

This procedure concerns the second phase of monitoring medicines. It aims to ensure the ongoing safety and effectiveness of medicinal products available on the market after they have been approved. This impacts pharmaceutical companies, healthcare professionals, and ultimately patients, by strengthening post-market surveillance and pharmacovigilance systems.